Prostate cancer is one of the most commonly diagnosed cancers among men, and choosing the right surgeon can significantly impact both survival and quality-of-life outcomes. The following list highlights some of the top prostate cancer surgeons in the United States, recognized for their expertise, surgical innovation, and exceptional patient care. Each of these specialists is renowned for their contributions to robotic-assisted radical prostatectomy, minimally invasive urologic oncology, and nerve-sparing surgical techniques that help preserve continence and sexual function.
This list includes experts from leading hospitals such as Memorial Sloan Kettering Cancer Center (New York), Mount Sinai Health System (New York), USC Institute of Urology (Los Angeles), UCSF (San Francisco), and MD Anderson Cancer Center (Texas). These surgeons are also recognized by organizations like Newsweek’s America’s Best Cancer Doctors (2024) and the American Urological Association for their clinical excellence and research leadership.
Dr. James A. Eastham is a highly renowned and leading specialist in prostate cancer, particularly in the surgical treatment of the disease.
Specialty: Urologic Surgery (Urology)
Primary Focus: Prostate Cancer
Affiliation: Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY
Position: Chief of the Urology Service and the Peter T. Scardino Chair in Oncology at MSKCC.
Key Expertise: Robotic-Assisted Radical Prostatectomy (nerve-sparing surgery to preserve sexual function and continence), Salvage Radical Prostatectomy (surgery for cancer recurrence after radiation therapy), Active Surveillance, and Focal Therapy.
Experience: Devoted his practice almost exclusively to the care of men with prostate cancer for over 15 years.
Location: MSK Urology, 353 E 68th St, New York, NY 10065.
Dr. Sanjay Razdan is a highly distinguished and internationally recognized urologist and prostate cancer surgeon, primarily known for his extensive expertise in robotic-assisted radical prostatectomy (RARP).
Specialization: Robotic Prostate Surgery (Radical Prostatectomy & Salvage Procedures), Prostate Cancer Treatment
Surgical Experience: Over 10,000 robotic prostate surgeries performed
Key Expertise: Nerve-sparing radical prostatectomy, Salvage robotic surgery (after radiation/HIFU), MRI-fusion guided biopsy, Functional preservation (continence & erectile function)
Education & Training: MBBS, MCh (Urology), FRCS (Glasgow) — Top of medical class with multiple gold medals
Recognitions & Awards:
Location: 3650 NW 82nd Avenue, Suite PH 501, Doral, FL 33166.
Dr. Ash Tewari (Icahn School of Medicine at Mount Sinai, New York City): Chair of Urology and world leader in robotic prostate surgeries, having performed more than 9,000 procedures.
Specialty Areas: Robotic prostatectomy (minimally invasive surgery for prostate cancer), urologic oncology (prostate, bladder, other genitourinary cancers).
Surgical Experience: Has performed thousands of robotic prostatectomy procedures (variously quoted as over 9,000 in recent sources).
Education & Training:
Recognition & Awards: Gold Cystoscope Award by American Urological Association (2012) for contributions to urologic oncology.
Location: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY (offices at 5 E 98th St and in Manhattan).
Dr. Ronney Abaza is an internationally recognized Urologic Surgeon who is considered a world leader and innovator in advanced robotic surgery for urologic cancers and other conditions.
Specialty: Robotic urologic oncology: prostate, kidney, bladder cancers and complex urologic surgeries using robotic techniques.
Robotic Surgery Volume: Has performed thousands of robotic surgeries (over 6,000 – 8,000+ reported) making him one of the most experienced robotic urologic surgeons.
Education & Training:
Recognition: Recognized by Newsweek as one of America’s Best Prostate Cancer Surgeons (2024) and frequently listed in Castle Connolly America’s Top Doctors.
Location: Columbus, Ohio (Practices with Central Ohio Urology Group and OhioHealth).
Dr. Mehrad Adibi is a fellowship-trained Urologic Oncologist specializing in the surgical treatment of the full range of genitourinary cancers, with significant expertise in both complex open and minimally invasive/robotic surgical approaches.
Primary Specialty: Urologic Oncology (a subspecialty of Urology)
Key Cancers: Prostate Cancer (including robotic prostatectomy), Bladder Cancer, Kidney Cancer, and other rare genitourinary cancers (adrenal, testicular, upper tract urothelial carcinoma).
Surgical Expertise: Highly proficient in robotic-assisted surgery (including complex prostate, bladder, and kidney surgeries) and traditional open surgical techniques.
Education & Training:
Location: Offices at MD Anderson League City / UTMB Health League City, TX.
Dr. Kent L. Adkins is a board-certified Urologist practicing in the St. Louis, Missouri area, with over two decades of experience in general adult urology and the treatment of various urologic conditions, including prostate cancer.
Primary Specialty: Urology (Board Certified by the American Board of Urology)
Focus Area: General Adult Urology, Prostate Cancer (including robotic assist prostatectomy and biopsy), Urinary Incontinence, and Urinary Stone Disease.
Surgical Expertise: Experienced in a variety of procedures, including Prostatectomy with Robotic Assist, TURP (Transurethral Resection of Prostate), Lithotripsy (for kidney stones), and Incontinence Sling Procedures.
Education & Training: Graduated summa cum laude from Bucknell University. Received his medical degree from the University of Virginia School of Medicine. Completed his Residency in Urologic Surgery at Vanderbilt University in Nashville, TN.
Dr. Monty A. Aghazadeh is a board-certified Urologist with a specialization in Minimally Invasive Surgery, Urologic Oncology, and Endourology. He is based in the Houston, Texas area.
Subspecialties: Minimally Invasive Urology, Urologic Oncology, and Endourology and Stone Disease.
Key Clinical Interests: Complex Kidney Stone Disease, Urologic Oncology (Prostate, Bladder, Kidney cancer), Benign Prostatic Hyperplasia (BPH), Adrenal conditions, Men’s Health, and Ureteral Reconstruction.
Surgical Expertise: Highly trained in minimally invasive surgery and uses advanced robotic technology for complex procedures like radical prostatectomy and nephrectomy.
Education & Training:
Office Location: 18300 Katy Freeway, Suite 325, Houston, TX 77094
Dr. Thomas E. Ahlering is an internationally recognized Urologic Oncologist and a major pioneer in the field of robotic surgery for prostate cancer. He is based in Orange County, California.
Specialty Areas: Urologic oncology (prostate, bladder, kidney, testicular cancers), robotic-assisted radical prostatectomy (RARP).
Surgical Volume: Has performed more than 2,500 robotic prostatectomies.
Research Focus: His extensive research (over 400 published abstracts/articles) concentrates on maximizing functional recovery (continence and potency) and patient-reported outcomes following RARP. He has also conducted significant work on the role of tumor volume over positive surgical margins in predicting outcomes.
Other Urologic Cancers: Also has extensive experience in the surgical treatment of bladder, kidney, and testicular cancers, and has expertise in urinary diversion and reconstruction (e.g., Indiana pouch, Ileal Neo-bladder) from his fellowship training.
Location: UCI Health Center for Urological Care, 101 The City Drive South, Orange, CA 92868.
Dr. Karim A. Touijer is a highly distinguished Urologic Oncologist known for his expertise in minimally invasive and robotic surgery for genitourinary cancers, particularly prostate and kidney cancer. He holds a prominent position at one of the world’s leading cancer institutions.
Specialty Areas: Urologic oncology- cancers of the prostate, kidney, bladder, adrenal; minimally invasive (laparoscopic/robotic) surgery; nerve-sparing techniques.
Education & Training: Holds an MD and a Master of Public Health (MPH) from Harvard School of Public Health. Completed a Fellowship in Urologic Oncology and Advanced Laparoscopy at MSKCC.
Nerve-Sparing Techniques: A major focus is on nerve-sparing surgery to maximize the preservation of urinary continence and sexual function, even in high-risk cancer cases.
Location: Office at MSK: 353 E 68th St, New York, NY 10065
Dr. Inderbir S. Gill is an internationally recognized Urologic Surgeon and one of the world’s most prominent pioneers in minimally invasive and robotic surgery for urologic cancers, particularly kidney, prostate, and bladder cancer.
Specialty Areas: Urologic oncology (prostate, kidney, bladder cancers), minimally invasive and robotic urologic surgery, focal/targeted therapy.
Key Leadership Roles: Chairman and Distinguished Professor of the Catherine and Joseph Aresty Department of Urology; Founding Executive Director of the USC Institute of Urology.
Global Recognition: Numerous international honors, including the St. Paul’s Medal from the British Urological Association and the Dr. B.C. Roy National Award (India), recognizing his global impact on the field.
Location: USC Institute of Urology, Los Angeles, CA.
Dr. Scott E. Eggener is a nationally recognized Urologic Oncologist and a major leader in the management and research of prostate, kidney, and testicular cancers. He is a prominent figure in academic medicine and is known for his work on reducing the overtreatment of prostate cancer.
Primary Specialty: Urologic Oncology (Minimally Invasive and Open Surgery)
Clinical Expertise: High-volume robotic and open surgeon specializing in the care of patients with prostate, kidney, and testicular cancers. Was the founding director of the High-Risk and Advanced Prostate Cancer Clinic at the University of Chicago.
Education & Training:
Dr. Matthew R. Cooperberg is a highly distinguished Urologic Oncologist known for his dual expertise as a surgeon specializing in urologic cancers and a leading health services researcher focused on prostate cancer outcomes. He is based in San Francisco, California.
Primary Specialty: Urologic Oncology (Surgeon and Researcher)
Focus Areas: Prostate Cancer (diagnosis, risk stratification, management), Kidney Cancer, and Bladder Cancer.
Surgical Expertise: Highly experienced in Minimally Invasive Techniques for urologic cancers, including Robotic-Assisted Radical Prostatectomy and laparoscopic/endoscopic procedures.
Location: UCSF Urologic Surgical Oncology Clinic, 1825 4th St., Sixth Floor, San Francisco, CA 94158.
Conclusion
Selecting a surgeon for prostate cancer treatment is a crucial decision that should be based on experience, specialization, and patient outcomes. The doctors profiled in this report—such as Dr. James A. Eastham, Dr. Ashutosh K. Tewari, Dr. Sanjay Razdan, Dr. Inderbir S. Gill, and others—represent the forefront of modern urologic oncology. Their collective contributions have redefined standards in prostate cancer surgery, emphasizing both oncologic precision and quality-of-life preservation.
If you are searching for the “top prostate cancer surgeons in the USA“, or the “best robotic prostate cancer doctors“, these names are trusted globally for their skill, innovation, and patient-focused outcomes.
Prostate cancer treatment often involves a combination of hormonal therapy, chemotherapy, and targeted medicines designed to slow cancer growth and manage symptoms. Below are some commonly prescribed options:
Abirakast (Abiraterone Acetate 250mg Tablets) is used to treat advanced prostate cancer by reducing androgen production, helping to slow cancer growth.
| Composition | Abiraterone Acetate (250mg) |
| Manufacturer | Aprazer Healthcare Pvt. Ltd. |
| Packing | 120 tablets in 1 bottle |
| Expiry | December 2027 |
| Buy Now |
Abirapro (Abiraterone Acetate 250mg Tablets) helps treat advanced prostate cancer by lowering androgen levels to slow cancer growth.
| Composition | Abiraterone Acetate (250mg) |
| Manufacturer | Glenmark Pharmaceuticals |
| Packing | 120 tablets in 1 bottle |
| Expiry | December 2027 |
| Buy Now |
Indenza (Enzalutamide 40mg Capsules) is used to treat prostate cancer by blocking androgen receptors, helping to slow cancer growth.
| Composition | Enzalutamide 40mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 112 Capsules |
| Expiry | December 2027 |
| Buy Now |
Obnyx (Enzalutamide 40mg Capsules) helps treat prostate cancer by blocking androgen receptors to slow cancer growth.
| Composition | Enzalutamide |
| Manufacturer | Zydus Cadila |
| Packing | 7 Capsules |
| Expiry | December 2027 |
| Buy Now |
Bdenza (Enzalutamide 40mg Capsules) is used to treat advanced prostate cancer by blocking androgen receptors and slowing cancer growth.
| Composition | Enzalutamide |
| Manufacturer | Prakash Biopharma |
| Packing | 112 Capsules |
| Expiry | December 2027 |
| Buy Now |
Bdron (Abiraterone Acetate 500mg Tablets) is used to treat advanced prostate cancer by lowering androgen levels to slow cancer growth.
| Composition | Abiraterone Acetate |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 60 Tablets |
| Expiry | December 2027 |
| Buy Now |
